Not known Factual Statements About Healthcare News
Novo CEO pressed by Senate to cut charges of obesity, diabetic issues medications CEO Lars Fruergaard Jørgensen told lawmakers the corporate would think about new talks with insurers about the listing price ranges of Wegovy and copyright when they pledge to maintain the medicines on their own formularies.The deal have to be accomplished by Sept. 3